Model-Based Cost–Utility Analysis of Erythropoiesis-Stimulating Agents for the Treatment of Cancer-Treatment Induced Anaemia in the UK NHS
Nov 1, 2014, 00:00 AM
10.1016/j.jval.2014.08.2316
https://www.valueinhealthjournal.com/article/S1098-3015(14)04246-6/fulltext
Section Title :
Disease-Specific Studies
Section Order :
1768
First Page :
A641
https://www.valueinhealthjournal.com/action/showCitFormats?pii=S1098-3015(14)04246-6&doi=10.1016/j.jval.2014.08.2316